New Function for Safety Signal Monitoring in MID‐NET®: The Case of an Anti‐COVID‐19 Drug
ABSTRACT Real‐world data play a key role in monitoring drug safety at the post‐marketing stage. However, challenges on how to rapidly and continuously obtain analytical results of many outcomes for drug safety signal monitoring still remain. We aimed to establish a rapid and continuous monitoring to...
Saved in:
| Main Authors: | Yusuke Okada, Takashi Ando, Fumitaka Takahashi, Kenichi Watanabe, Kazuhiro Kajiyama, Tomoaki Hasegawa, Satomi Inomata, Yuki Kinoshita, Shinya Watanabe, Yoshiaki Uyama |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | Clinical and Translational Science |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/cts.70208 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk of Thrombocytopenia by SSRIs or SNRIs in Patients With Depression Based on MID‐NET: A Cohort Study in Japan
by: Yusuke Okada, et al.
Published: (2025-06-01) -
Risk of neutropenia in psoriasis patients prescribed anti-IL-23 antibody in comparison with anti-IL-17 antibody or adalimumab based on real-world data from the MID-NET® in Japan
by: Yusuke Okada, et al.
Published: (2024-12-01) -
Overcoming HPV Vaccine Hesitancy in Japan: A Narrative Review of Safety Evidence, Risk Communication, and Policy Approaches
by: Takayuki Takahashi, et al.
Published: (2025-05-01) -
An Ontology Framework for ERBS (Evidence/Risk-Based Safety) Management of Divisional and Subdivisional Works with High Risk
by: Jianjun She, et al.
Published: (2024-11-01) -
Atorvastatin: evidence base 15 years later
by: A. V. Susekov, et al.
Published: (2011-06-01)